Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,205,306
  • Shares Outstanding, K 47,375
  • Annual Sales, $ 388,540 K
  • Annual Income, $ -13,360 K
  • EBIT $ 26 M
  • EBITDA $ 50 M
  • 60-Month Beta 1.60
  • Price/Sales 5.75
  • Price/Cash Flow 56.52
  • Price/Book 5.07

Options Overview Details

View History
  • Implied Volatility 72.45% (-6.73%)
  • Historical Volatility 32.37%
  • IV Percentile 83%
  • IV Rank 15.45%
  • IV High 343.80% on 11/28/25
  • IV Low 22.85% on 01/22/25
  • Expected Move (DTE 27) 5.10 (10.96%)
  • Put/Call Vol Ratio 0.50
  • Today's Volume 3
  • Volume Avg (30-Day) 35
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 184
  • Open Int (30-Day) 31,678
  • Expected Range 41.45 to 51.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.14
  • Number of Estimates 1
  • High Estimate 0.14
  • Low Estimate 0.14
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.68 +9.07%
on 12/10/25
48.25 -3.52%
on 12/17/25
+1.92 (+4.30%)
since 11/19/25
3-Month
38.95 +19.51%
on 10/01/25
48.25 -3.52%
on 12/17/25
+6.00 (+14.80%)
since 09/19/25
52-Week
21.97 +111.88%
on 04/09/25
48.25 -3.52%
on 12/17/25
+18.58 (+66.43%)
since 12/19/24

Most Recent Stories

More News
3 Cash-Producing Stocks with Questionable Fundamentals

3 Cash-Producing Stocks with Questionable Fundamentals

HLF : 13.99 (-1.55%)
BKD : 10.79 (+1.12%)
AORT : 46.55 (-1.27%)
Artivion (AORT) Stock Is Up, What You Need To Know

Artivion (AORT) Stock Is Up, What You Need To Know

AORT : 46.55 (-1.27%)
3 Russell 2000 Stocks That Concern Us

3 Russell 2000 Stocks That Concern Us

LADR : 11.38 (-0.35%)
TRNS : 59.55 (-1.23%)
AORT : 46.55 (-1.27%)
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest

AORT : 46.55 (-1.27%)
Oscar Health and Artivion Shares Are Soaring, What You Need To Know

Oscar Health and Artivion Shares Are Soaring, What You Need To Know

OSCR : 14.90 (+0.68%)
AORT : 46.55 (-1.27%)
5 Must-Read Analyst Questions From Artivion’s Q3 Earnings Call

5 Must-Read Analyst Questions From Artivion’s Q3 Earnings Call

AORT : 46.55 (-1.27%)
3 Small-Cap Stocks We Approach with Caution

3 Small-Cap Stocks We Approach with Caution

HI : 31.66 (-0.09%)
DXC : 15.43 (+0.26%)
AORT : 46.55 (-1.27%)
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

GILD : 124.29 (+2.32%)
CRL : 197.06 (+1.66%)
MRNA : 33.80 (+9.21%)
AORT : 46.55 (-1.27%)
THC : 196.33 (+1.01%)
2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges

2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges

HLT : 292.25 (+1.59%)
POWL : 332.90 (+1.26%)
AORT : 46.55 (-1.27%)
AORT Q3 Deep Dive: AMDS and On-X Outperform, Pipeline and Reimbursement Bolster Outlook

AORT Q3 Deep Dive: AMDS and On-X Outperform, Pipeline and Reimbursement Bolster Outlook

AORT : 46.55 (-1.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants....

See More

Key Turning Points

3rd Resistance Point 48.10
2nd Resistance Point 47.75
1st Resistance Point 47.15
Last Price 46.55
1st Support Level 46.20
2nd Support Level 45.85
3rd Support Level 45.25

See More

52-Week High 48.25
Last Price 46.55
Fibonacci 61.8% 38.21
Fibonacci 50% 35.11
Fibonacci 38.2% 32.01
52-Week Low 21.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar